[Antineoplastic activity of L-asparaginase].
D000208:Acute Disease; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D002648:Child; D004285:Dogs; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy
D000970:Antineoplastic Agents; D001215:Asparaginase
Antitumorska aktivnost L-asparaginaze.